In-vitro validation of potential modulators of non-alcoholic fatty liver disease (NAFLD)
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver injury, compromising the liver’s regenerative ability and promoting fibrosis. Despite its widespread impact, therapeutic options remain limited. The only FDA-approved drug for NASH, Rezdiffra, had limited efficacy in pat...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/181271 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |